Evidence map›Paper›PMID 28597974›Full record

ArticleBiotechnology progress2017

A simple cell transport device keeps culture alive and functional during shipping.

Paula G Miller, Ying I Wang, Glen Swan, Michael L Shuler

Abstract read
In one paragraph

Article in Biotechnology progress, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Paula G MillerNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853.ORCID http://orcid.org/0000-0002-9027-9679
Ying I WangNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853.
Glen SwanRobert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, 14853.
Michael L ShulerNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853.

Funding

Populating MPS database with data from multi-organ, human-on-a-chip microphysiological systemsR44TR001326 · NCATS · HESPEROS, LLC · PI HICKMAN, JAMES J, SHULER, MICHAEL L · 2016 to 2021
$6.5M
Colorado Clinical and Translational Science Institute (KL2)KL2TR000156 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$521k
NCATS NIH HHS KL2 TR000156NCATS NIH HHS R44 TR001326
6 · The paper itself

Abstract

Transporting living complex cellular constructs through the mail while retaining their full viability and functionality is challenging. During this process, cells often suffer from exposure to suboptimal life-sustaining conditions (e.g. temperature, pH), as well as damage due to shear stress. We have developed a transport device for shipping intact cell/tissue constructs from one facility to another that overcomes these obstacles. Our transport device maintained three different cell lines (Caco2, A549, and HepG2 C3A) individually on transwell membranes with high viability (above 97%) for 48 h under simulated shipping conditions without an incubator. The device was also tested by actual overnight shipping of blood brain barrier constructs consisting of human induced pluripotent brain microvascular endothelial cells and rat astrocytes on transwell membranes to a remote facility (approximately 1200 miles away). The blood brain barrier constructs arrived with high cell viability and were able to regain full barrier integrity after equilibrating in the incubator for 24 h; this was assessed by the presence of continuous tight junction networks and in vivo-like values for trans-endothelial electrical resistance (TEER). These results demonstrated that our cell transport device could be a useful tool for long-distance transport of membrane-bound cell cultures and functional tissue constructs. Studies that involve various cell and tissue constructs, such as the "Multi-Organ-on-Chip" devices (where multiple microscale tissue constructs are integrated on a single microfluidic device) and studies that involve microenvironments where multiple tissue interactions are of interest, would benefit from the ability to transport or receive these constructs. © 2017 American Institute of Chemical Engineers Biotechnol. Prog., 33:1257-1266, 2017.

Indexed as

BiotechnologyCell Culture TechniquesCell LineCell SurvivalEquipment DesignHumansSpecimen Handlingblood brain barriercellular and tissue constructsTEERtransporting devicetranswell inserts

Identifiers

PMID28597974
PMCPMC5647209

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.